Bristol-Myers Squibb Company (USA): Results of Voluntary Exchange Offer with Mead Johnson Nutrition Company (USA)
Changes In FTSE Indices

18 December 2009


Following the completion of the voluntary exchange offer by Bristol-Myers Squibb (USA, constituent) with Mead Johnson Nutrition (USA, non constituent), FTSE announces the following changes:

INDEXCHANGEEFFECTIVE FROM
START OF TRADING
FTSE All-World IndexBristol-Myers Squibb(USA, 2126335) will remain in the index with a decreased shares in issue total of 1,711,694,540 and an unchanged investability weighting of 100%.

22 December 2009
FTSE MultinationalsBristol-Myers Squibb will remain in the index as detailed above.22 December 2009
FTSE Global 100Bristol-Myers Squibb will remain in the index as detailed above.22 December 2009
FTSE Global Sector - PharmaceuticalsBristol-Myers Squibb will remain in the index as detailed above.22 December 2009
FTSE Global Style IndexBristol-Myers Squibb will remain in the index as detailed above.22 December 2009

FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or general enquiries please contact us at info@ftse.com or call:
Client Services in UK:Tel: +44 (0) 20 7866 1810
Client Services in Europe, Middle East & Africa:Tel: +44 (0) 20 7866 1810
Client Services in US:New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139
Client Services in Asia Pacific:Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811

Alternatively please visit our website at www.ftse.com


Terms of Use | Copyright © FTSE